News Digest: VC Investments in Medtech Holds Steady in Q2
August 23, 2024
News Digest:
Having gone through a dry spell in the past, the medtech startups became an attractive option for venture capitalists in the second quarter. A news report suggests that investment activity could surpass last year’s figures and VCs may also find more exits.
Overall the VC investments in medtech held steady during the second quarter, posting deal values of around $3.3 billion, which was slightly lower than the $3.5 billion over the first quarter. While this represents a 7% decline over subsequent quarters, it is still a gain of 3.2% when compared to numbers from a year ago.
Takeaway:
The report noted that this marked the second straight quarter of higher deal activity in the medtech sector, when compared to those achieved in 2023. Through the first half of 2024, VC investment in medtech stood at $6.8 billion. In Q1, 206 deals were closed, with full-year numbers appearing to be on track to close 20% higher than in 2023.